Lactose (India) Ltd | 141 Cr. | 112 | 247/84.3 | 32.1 | 46.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 4.09 Cr. | 2.14 | 4.33/2.14 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,163 Cr. | 382 | 411/192 | 93.4 | 22.8 | 0.18 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 31.3 Cr. | 42.2 | 94.9/39.0 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 30.8 Cr. | 21.0 | 29.1/17.0 | 32.1 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 63.1 Cr. | 83.8 | 155/79.0 | 16.6 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 54,304 Cr. | 1,924 | 2,286/1,275 | 40.8 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 270 Cr. | 11.8 | 29.0/11.2 | 16.4 | 8.21 | 0.00 % | 12.5 % | 9.09 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.6/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 549 Cr. | 1,164 | 1,329/635 | 23.4 | 299 | 0.06 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 107 Cr. | 21.4 | 32.0/15.0 | 32.7 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 971 Cr. | 330 | 449/219 | 9.29 | 123 | 0.76 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 5.46 Cr. | 26.0 | 39.0/22.8 | 42.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 7.63 Cr. | 3.07 | 9.50/2.11 | 85.0 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 383 Cr. | 395 | 477/112 | 61.7 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,161 Cr. | 1,186 | 1,584/1,078 | 50.3 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 143 Cr. | 0.70 | 1.24/0.48 | 9.41 | 1.02 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 45.7 Cr. | 19.0 | 26.3/6.40 | 47.1 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 11.2 Cr. | 11.0 | 18.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 159 Cr. | 446 | 999/443 | 8.63 | 563 | 0.45 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 62.0 Cr. | 62.0 | 67.0/26.1 | 159 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 18.2 Cr. | 39.8 | 88.7/37.9 | 37.9 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 8.22 Cr. | 3.29 | 8.15/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 17.8 Cr. | 119 | 154/59.6 | | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 16.2 Cr. | 29.7 | 45.4/6.34 | 181 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 41.3 Cr. | 54.7 | 85.5/0.00 | 48.0 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 7.02 Cr. | 23.4 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 11,568 Cr. | 668 | 1,028/460 | 32.3 | 65.3 | 0.18 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 93.0 Cr. | 21.5 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 12.8 Cr. | 25.2 | 46.0/17.4 | 55.6 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 189 Cr. | 327 | 418/241 | 19.8 | 119 | 1.37 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 53.0 Cr. | 36.9 | 62.6/19.1 | 47.7 | 17.7 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 60,091 Cr. | 1,028 | 1,593/994 | 17.7 | 557 | 0.44 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 129 Cr. | 207 | 303/170 | 187 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 875 Cr. | 87.4 | 123/74.0 | 19.0 | 32.5 | 1.72 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 34.9 Cr. | 26.7 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Acutaas Chemicals Ltd | 11,519 Cr. | 1,406 | 1,445/676 | 60.9 | 160 | 0.11 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.56 Cr. | 0.69 | 1.45/0.67 | 91.2 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 241 Cr. | 31.4 | 69.5/30.0 | 12.8 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 10.5 Cr. | 18.0 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 118 Cr. | 5.00 | 6.25/2.82 | 214 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 66,862 Cr. | 31,480 | 37,000/25,260 | 46.0 | 1,992 | 1.51 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,639 Cr. | 841 | 972/550 | 28.7 | 220 | 0.59 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 168 Cr. | 60.2 | 75.8/31.3 | 40.3 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 3,638 Cr. | 1,200 | 1,397/535 | | 78.1 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 23,191 Cr. | 1,428 | 1,870/915 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 914 Cr. | 278 | 330/154 | 21.2 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 610 Cr. | 456 | 568/270 | 13.0 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,545 Cr. | 504 | 950/483 | 28.4 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,629 Cr. | 1,158 | 1,923/991 | 24.2 | 754 | 0.86 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,20,422 Cr. | 3,560 | 3,790/2,886 | 59.6 | 224 | 0.90 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 913 Cr. | 99.1 | 317/98.0 | | 43.7 | 0.50 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,570 Cr. | 16.7 | 27.9/14.1 | 27.6 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Cohance Lifesciences Ltd | 33,743 Cr. | 881 | 1,360/856 | 96.0 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 4,883 Cr. | 214 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,82,441 Cr. | 1,594 | 1,960/1,553 | 33.4 | 301 | 1.00 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,710 Cr. | 613 | 886/441 | 110 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,098 Cr. | 237 | 398/175 | 29.8 | 75.9 | 0.17 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 343 Cr. | 1,131 | 1,750/956 | 19.9 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 8,313 Cr. | 846 | 1,003/530 | 64.7 | 243 | 0.12 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 4,242 Cr. | 169 | 241/111 | 141 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 11,841 Cr. | 5,144 | 7,600/4,146 | 33.2 | 340 | 2.27 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,861 Cr. | 2,320 | 2,977/1,772 | 37.3 | 321 | 0.86 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,593 Cr. | 6,370 | 6,739/4,863 | 35.2 | 323 | 1.96 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 220 Cr. | 62.4 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 24,013 Cr. | 5,249 | 6,453/3,701 | 35.5 | 922 | 0.67 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 114 Cr. | 92.7 | 348/81.0 | 8.05 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,418 Cr. | 395 | 582/220 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,914 Cr. | 772 | 1,998/604 | 45.9 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 16,898 Cr. | 13,171 | 18,100/10,060 | 128 | 1,188 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 339 Cr. | 15.1 | 56.5/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,318 Cr. | 855 | 1,639/660 | 9.02 | 425 | 0.70 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,592 Cr. | 47.3 | 101/41.7 | 28.0 | 21.1 | 0.42 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 7,852 Cr. | 173 | 359/168 | 22.4 | 54.4 | 0.46 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 124 Cr. | 78.6 | 142/65.5 | | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 357 Cr. | 99.9 | 177/90.2 | 47.6 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 87,907 Cr. | 1,925 | 2,403/1,774 | 23.8 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,085 Cr. | 542 | 980/499 | 12.6 | 335 | 0.33 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 46,892 Cr. | 869 | 923/423 | 92.0 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,041 Cr. | 1,003 | 1,235/596 | 24.0 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 158 Cr. | 73.1 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 757 Cr. | 157 | 370/155 | 21.7 | 107 | 1.91 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 610 Cr. | 349 | 500/265 | 21.8 | 116 | 0.00 % | 17.3 % | 14.1 % | 10.0 |
Jubilant Pharmova Ltd | 16,534 Cr. | 1,037 | 1,310/802 | 34.0 | 393 | 0.48 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,737 Cr. | 1,706 | 1,998/1,303 | 39.0 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,552 Cr. | 233 | 328/152 | 36.4 | 36.1 | 1.07 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 36,097 Cr. | 1,418 | 1,758/1,168 | 40.4 | 274 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,671 Cr. | 90.9 | 108/57.5 | 25.4 | 57.5 | 0.88 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 690 Cr. | 93.5 | 160/67.2 | 31.3 | 194 | 0.00 % | 3.47 % | 3.50 % | 10.0 |
Indoco Remedies Ltd | 2,530 Cr. | 274 | 388/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 3,132 Cr. | 254 | 465/245 | 49.5 | 102 | 0.55 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,725 Cr. | 2,030 | 2,786/1,243 | 45.9 | 369 | 0.34 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,722 Cr. | 372 | 504/285 | 60.9 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 11,336 Cr. | 467 | 725/412 | 23.7 | 153 | 0.32 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 54,612 Cr. | 1,937 | 2,286/1,275 | 41.0 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,593 Cr. | 2,749 | 3,516/1,921 | 49.2 | 115 | 1.53 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 31,074 Cr. | 1,887 | 2,131/1,200 | 27.4 | 592 | 0.95 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,492 Cr. | 458 | 659/359 | 27.8 | 140 | 1.09 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 24,602 Cr. | 1,800 | 1,910/1,097 | 63.5 | 210 | 0.41 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,05,083 Cr. | 1,260 | 1,415/1,020 | 18.5 | 402 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,163 Cr. | 265 | 308/161 | 35.0 | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,28,527 Cr. | 1,589 | 1,702/1,310 | 23.8 | 386 | 0.82 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,941 Cr. | 2,099 | 2,641/1,551 | 28.2 | 375 | 0.29 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 392 Cr. | 135 | 203/95.6 | 193 | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,642 Cr. | 156 | 191/105 | 15.4 | 99.7 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 71.1 Cr. | 44.5 | 92.0/40.4 | 25.5 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 46,593 Cr. | 348 | 406/291 | 129 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,892 Cr. | 1,874 | 2,215/1,430 | 41.3 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 138 Cr. | 86.8 | 153/76.3 | 19.3 | 48.6 | 1.38 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 246 Cr. | 104 | 117/67.8 | 24.4 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 21,167 Cr. | 8,460 | 10,691/6,220 | 100 | 308 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,005 Cr. | 692 | 843/544 | 36.8 | 113 | 0.66 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 198 Cr. | 94.4 | 145/90.4 | 7.52 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 63,406 Cr. | 5,304 | 6,440/4,492 | 27.9 | 1,002 | 0.85 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,432 Cr. | 937 | 1,304/725 | 31.1 | 264 | 1.17 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 456 Cr. | 801 | 1,754/763 | 72.5 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 30,911 Cr. | 2,478 | 3,486/2,022 | 33.2 | 303 | 1.13 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,872 Cr. | 346 | 571/258 | 28.3 | 127 | 1.50 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,302 Cr. | 468 | 591/312 | 24.0 | 136 | 0.21 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,545.04 Cr | 1,158.48 | | 47.56 | 193.71 | 0.33% | 16.34% | 15.08% | 6.18 |